Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland.

Scandinavian journal of gastroenterology - 1 May 2000

Ebeling F, Lappalainen M, Vuoristo M, Nuutinen H, Leino R, Karvonen A L, Lehtola J, Julkunen R, Pohjanpelto P, Tölö H, Färkkilä M

Abstract excerpt

BACKGROUND: To evaluate the efficacy of leukocyte interferon in previously untreated patients with chronic hepatitis C, 97 patients were enrolled in a prospective study in Finland with a stepped-care management protocol. METHODS: The treatment was initiated with 3 million units of interferon-alpha subcutaneously three times a week. At 3 months, if the serum alanine aminotransferase was still abnormal, the dose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Finland
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Risk Factors

Share to RNA, Viral

Share to Treatment Outcome

Source

Identifiers

PMID: 10868459
DOI: 10.1080/003655200750023822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leukocyte interferon-alpha in the treatment of chronic hepatitis C in Finland.PMID 10868459Read ↗

Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.Semantic proximity Read ↗

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.Semantic proximity Read ↗

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.Semantic proximity Read ↗

Alpha interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.Semantic proximity Read ↗

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.Semantic proximity Read ↗

Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.Semantic proximity Read ↗

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.Semantic proximity Read ↗

Incidence and associated factors of neutralizing anti-interferon antibodies among chronic hepatitis C patients treated with interferon in Taiwan.Semantic proximity Read ↗

Management of chronic hepatitis C in childhood: the impact of therapy in the clinical practice during the first 2 decades.Semantic proximity Read ↗

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.